Trial · NCT00399529
Results by group32
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 32
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Adverse Events | Allo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide | Fatigue | 8 | Participants | |
| Number of Participants With Adverse Events | Allo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide | Urticaria | 7 | Participants | |
| Number of Participants With Adverse Events | Allo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide | Pruritus | 6 | Participants | |
| Number of Participants With Adverse Events | Allo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide | Fever | 5 | Participants | |
| Number of Participants With Adverse Events | Allo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide | Flu-like symptoms | 4 | Participants | |
| Number of Participants With Adverse Events | Allo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide | Lymphadenopathy | 4 | Participants | |
| Number of Participants With Adverse Events | Allo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide | Abdominal pain | 3 | Participants | |
| Number of Participants With Adverse Events | Allo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide | Rash | 3 | Participants | |
| Number of Participants With Adverse Events | Allo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide | Malaise | 3 | Participants | |
| Number of Participants With Adverse Events | Allo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide | Chills | 3 | Participants | |
| Number of Participants With Adverse Events | Allo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide | Dizziness | 2 | Participants | |
| Number of Participants With Adverse Events | Allo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide | Anorexia | 1 | Participants | |
| Number of Participants With Adverse Events | Allo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide | Erythema | 1 | Participants | |
| Number of Participants With Adverse Events | Allo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide | Headache | 1 | Participants | |
| Number of Participants With Adverse Events | Allo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide | Nausea | 1 | Participants | |
| Number of Participants With Adverse Events | Allo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide | Arm pain | 1 | Participants | |
| Number of Participants With Adverse Events | Allo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide | Cancer site pain | 1 | Participants | |
| Number of Participants With Adverse Events | Allo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide | Leg pain | 1 | Participants | |
| Number of Participants With Adverse Events | Allo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide | Groin tightness | 1 | Participants | |
| Number of Participants With Adverse Events | Allo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide | Erythema at vaccine sites | 20 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00399529/results